A change in official GAAP accounting rules will send one of America's best-loved tech stocks into orbit. The new rule will boost reported earnings by +58% -- a killer catalyst for the stock. See below for exactly how this will work.
	Detroit will release a car in 2010 that gets 230 miles per gallon. For distances under 40 miles, it will run solely on batteries, allowing millions of commuters to go gas-free indefinitely. But don't buy the car -- buy the battery maker we profile below instead.
	Microsoft will buy out a national retail chain with 5,264 stores, giving it instant access to millions of new customers. Investors who own the retailer's stock will pocket a windfall profit of +61%. But play it another way and you could earn +1,300%. See below for full details.
	Sugar prices will plummet. After a monster 11-month move from 12 cents to 26 cents per pound (hitting its highest level since 1981) sugar is due for a breather in 2010. We've found a safe and cheap way to play the move that can turn $3,000 into $27,000 in a matter of weeks.
	Treasuries will crash as interest rates skyrocket from 3% to 7% in a year. The Federal Reserve will raise rates aggressively in 2010 to fight inflation. Bond investors will lose trillions. But shrewd investors who position themselves in "reverse-bond" securities will clean up. See below for details.
	The release of Windows 7 will unleash a tidal wave of business spending, spurring sales up and down the IT chain, from chips to PC makers to retailers. For the biggest beneficiaries, see below.
	The U.S. dollar will continue to plummet in 2010. Trillions in unpayable liabilities are coming due on Social Security and Medicare. Meanwhile, Washington spends money like a drunken sailor. Keep reading to see how every cent it drops can make you richer.
	The world's 8th largest economy will legalize marijuana in 2010. This will raise $2 billion in tax revenue, save hundreds of millions in law enforcement and prison costs, and spark a rush into the stock of the only pharmaceutical company using marijuana to treat swine flu. More on this further in this report.

They Told Us We were Crazy to Go Public With Our Predictions

     Oil Will Soar in 2010 -- Bursting Through
Its Old Top and Hitting $185 per Barrel

     Enjoy oil now while it's cheap, because it will cost twice as much next year.

We predict that Israel will launch an airstrike in 2010 against Iran's uranium-enrichment plant buried under a mountain range 100 miles southwest of Tehran. Iran will retaliate by showering missiles on Tel Aviv and will blockade the Strait of Hormuz.      Oil prices will soar to $185 per barrel in the panic.      Even if Israel doesn't attack Iran, oil prices are under serious pressure. Declines in production, exploration and the dollar will drive oil prices substantially higher in the years ahead.

     All the easy oil has been found... big strikes are now extremely rare... and two major oil exporters -- Indonesia and China -- now import the stuff.

     Meanwhile, the world's largest fields are all declining... from the Persian Gulf, to the North Sea, to the Gulf of Mexico, to Alaska.

     OPEC is shutting off the spigot. OPEC has cut production by 12% of its capacity -- dramatically reducing the amount of oil coming to market.

     Plus the dollar is weakening... and crude oil thrives on a weak dollar. When it doubled from July 2007 to July 2008, soaring from $74 to $147 a barrel, a major catalyst was the rapid decline of the dollar.

     Global energy exploration is off sharply and future supplies are already jeopardized. When oil dropped after its 2008 surge, expensive energy projects like oil sands were put on hold. Oil drilling activity dropped 43%, with year-over-year oil exploration in the United States alone down 38%. Bids for offshore drilling rights in the Gulf of Mexico dropped by 80%.

     Bottom line: With a weak dollar and reduced production bolstering oil prices, we'll see a dramatic spike in crude oil as the world economy picks up. And if war breaks out in the Mideast, as we think it will, all bets are off.

     The best way to profit? In the stocks of a few large integrated oil companies that are trading at bargain prices.

     In Hottest Investment Opportunities for 2010, you'll find two oil giants currently trading at multi-year lows. These companies have more cash in the bank than debt on their books. What's more, they are steadily increasing their dividends.

     These companies can continue to post profits even if oil and natural gas prices drop. They have multiple profit centers and their refining and marketing profits will expand if spot prices decline.

     A third favorite is an offshore deep-driller that recently made the world's largest oil discovery in 32 years. It is doubly attractive as a foreign company because it will get an additional boost as the dollar slides.
 

Best ''Fear Trade'' of 2010: The Swine Flu Pandemic
Will Worsen and a Handful of Biotech Stocks Will Soar

     The swine flu virus will spread in 2010. The media circus may have quieted down, but more than 70 countries now report cases of the virus and the number is growing.

The World Health Organization is has raised its pandemic alarm to full alert for the first time since 1968.      One million Americans are already infected. The X factor is that epidemiologists don't know how it will react when it mixes with regular seasonal flu, which already kills 36,000 Americans a year.      Public health officials say an influenza pandemic could kill 71 million people worldwide. To fend off catastrophe, the U.S. and other governments around the world are spending billions to stockpile antiviral drugs and vaccines.

     The U. S. government has already set aside $1 billion to develop the vaccine to fight the virus. A nationwide H1N1 vaccination program will cost between $3 billion and $18 billion.

     The strong government response to this pandemic could lead to big profits for several drugmakers. You'll find their names in Hottest Investment Opportunities for 2010.

     Roche, Novartis, GlaxoSmithKline and Sanofi-Aventis are all working on vaccines. It's too soon to tell who will win the fattest contracts. But they are all so large that even a billion-dollar contract won't do much for the bottom line.

     In contrast, the CDC recently awarded a $35 million development contract to a small biotech company. This is the sort of company you should be looking to buy.

     We especially like a small clinical-stage biopharmaceutical company based in Maryland. When the swine flu story hit the news in April, this small flu-vaccine maker was trading for 81 cents. A day later the stock hit $3.88.

     That's a +379% jump in price overnight. A few small fortunes were made from this one simple fear trade.

     After surging as high as $7.79, this stock is now back in the $4 range. If the swine flu hits 40% of the U.S. population, as the Centers for Disease Control projects could happen, this stock could go on a rocket ride. You'll get full details on it in your free copy of Hottest Investment Opportunities for 2010.
 

Best Government-Driven Investment of 2010:
Bio-Generic Drugs

As the healthcare debate reaches fever pitch, it's clear that big changes are coming. As with any massive regulatory overhaul, some companies are cowering in fear of the proposals -- but others are chomping at the bit.      Partisan rancor aside, we all have a common enemy in spiraling costs. So it stands to reason that companies trimming fat from the system will have powerful allies on both sides of the political aisle.

     That makes the healthcare IT sector a safe bet. But stocks in this niche are already pricey. For real upside we like companies working to develop generic substitutes for biotech drugs. These medicines save lives, but can also be prohibitively expensive (cancer drug Avastin costs up to $100,000 annually).

     We think a resistance to cheaper biotech equivalents will soon melt away. Generic prescriptions now account for almost 70% of all pills taken nationwide. These inexpensive alternatives have saved more than $730 billion over the past decade.

     Biotechs have fended off generic imitators until now, but the copycats are about to break through. Bipartisan legislation pushing for a formal FDA approval pathway has been introduced in both the house and Senate.

     By next year, we'll see the FDA approving biogeneric medicines in the United States. The lure of shaving off one-third off the $40 billion we spend on biotech drugs each year will prove irresistible.

     The investment implications are huge. Washington's move will have a big impact on biotech companies like Amgen and Genentech, as well as traditional drugmakers like Merck who want to get into generic biotech.

     In Hottest Investment Opportunities for 2010 we profile the company that is best positioned of all to profit from the FDA's move. A regulatory green light could send this stock soaring.
 

Best "Sleeper" Play of the Year:
An Obscure Accounting Rule Change Will Send
One of America's Most-Loved Tech Stocks Into Orbit

     One of America's premier technology companies has a funny problem: too much cash.

     You see, it conservatively accounts for sales by spreading revenues over two years. But it gets the cash upfront. So its reported earnings are tiny compared to its actual cash flow.

     The official GAAP earnings investors see don't reflect this company's impressive profits. But that may soon change. A new accounting rule is in the works that would let the firm book most of its revenue upfront.

     Last quarter, its earnings per share would have been +58% higher under this new rule.

     Once the new rule is approved, Wall Street analysts will jack up their earnings estimates, the company's reported earnings will surge... and the stock will attract millions of new growth investors.

     You know this company. You probably use its products. And it's a great stock to own regardless of its accounting policies.

     For the full details, including the best timing to take advantage of this catalyst, send for your free copy of Hottest Investment Opportunities for 2010.
 

Best Automotive Investment of 2010: Detroit
Will Release a Car that Gets 230 Miles Per Gallon

A pal of mine brags about getting 50 miles per gallon in his Toyota Prius. But that's nothing compared to the 230 mpg that GM's new Chevy Volt will get.      For distances under 40 miles, the Volt runs on electricity. Then it switches to gas and the generator recharges the batteries.

     If you commute less than 40 miles a day you could swear off gasoline forever. Just plug in the car at night to recharge.

     GM isn't the only American carmaker going electric. Ford is planning a battery-powered car based on the Focus. And of course Toyota has the Prius... and Nissan the Leaf.

     This growing wave of battery-powered cars doesn't mean car makers are a good buy. It means battery makers are a good buy.

     But we're looking for profits far from Detroit. The United States is behind the technology curve here. China is the leader.

     While the Department of Energy is giving $2.6 billion to private industry to advance our battery technology, a Chinese battery maker is selling cutting-edge technology it has already developed.

     These aren't your father's Die Hards. These are state-of-the-art rechargeable lithium-ion batteries that outperform anything else being made.

     What's more, these batteries are 100% nontoxic. The CEO actually drinks the company's battery fluid to prove the point.

     Finally, they're cheap. Instead of using expensive robots on automated assembly lines, it uses cheap Chinese labor. It pays China's top engineering graduates about $700 a month, which wouldn't cover a GM shop steward's weekly wages.

     The more the world's carmakers rely on batteries, the more this company will sell of them. It already dominates the Chinese market and will inevitably build a larger footprint throughout the world. Buying it now is like buying stock from Sam Walton when all he owned was a couple of dime stores. See our full write-up in Hottest Investment Opportunities for 2010.
 

Best Takeover Play of 2010:
Microsoft's Next Shopping Spree Could Earn You +1,300%

     This past February Microsoft hired a veteran Wal-Mart executive to create a chain of brick-and-mortar retail stores. Apple has changed computer marketing with its hip stores, and Microsoft is serious about regaining lost ground.

     Wal-Mart executives get things done fast. And it's a lot quicker to buy what you need than to build it brick by brick -- especially when you have enough cash to buy anything you want.

     Microsoft has $8.3 billion in cash on hand, and no long-term debt. It is one of just seven U.S. companies with a triple-A credit rating.

     The company we think it will buy has an international footprint of 5,264 stores. They tend to be in shopping centers and strip malls... places where people already eat, shop and work.

     This is precisely where Microsoft wants to extend its reach. Buying this retailer will give Microsoft an instant competitive advantage over Apple, which has only 250 stores. Overnight, it achieves a footprint that otherwise would take years to build.

     So what's the profit potential here? Institutions own 91% of the target company's shares and they have suffered through a -54% decline in the past two years. I doubt they'll approve a merger that doesn't help make them whole, especially from a company that can afford to pay up. An acquisition at $45 a share would give shareholders a 61% premium and still price the company at less than its historical valuation.

     You have two ways to play this, depending on how aggressive you want to be: Buy the stock and wait for a takeover announcement that includes a rich premium... or position yourself for a huge payday with call options.

     In Hottest Investment Opportunities for 2010 you will see $1 options that could easily move to $14 if Microsoft pounces on this stock as we expect.
 

Best Commodity Play of 2010: Short Sugar and Buy Wheat

     You want to see a financial mania? Don't look at stocks, look at sugar.

     Sugar recently hit its highest price in 28 years as production in Brazil and India collapsed thanks to El Niño. Sugar prices touched 26 cents per pound, the most it's fetched since the shortage of 1981.

     Take a look at this chart:

     When a market goes vertical like this, a sell-off usually follows. Sugar has already dropped a few cents from its high, but it could drop a dime in a hurry. If you're short 10 sugar contracts, that's $112,000 in your pocket.

But don't play the futures on sugar. It's too expensive and risky. In Hottest Investment Opportunities for 2010, we explain a far safer strategy where you can still take advantage of a monster move in sugar.      If sugar retraces even half its move to the downside, you can turn $3,000 into $27,000 this way... likely in just weeks.

     The long side of our double-barreled commodities trade is wheat. After a long slide, the wheat market has finally come off its lows. Prices bottomed out on October 2 at $4.41 per bushel -- its cheapest price in almost three years.

     So far this year, weather conditions have been great. This is what pushed wheat prices down to new lows almost every week. But even the slightest hint of bad weather can turn the markets on a dime -- and trigger a powerful bullish move.

     Twice in just the past year wheat has spiked over $7 a bushel. It could easily do so again if any weather disruption occurs in the next few months. In that case, a long position in wheat is a quick path to wealth.

     With colder, wetter weather sweeping through the Midwest and hampering the harvest, the crop might come in smaller than predicted. We predict a rally in wheat up to $7 per bushel within six months.
    
     At around $5 a bushel now, you make $50 for each cent it moves in a futures contract. That's $10,000 profit per contract on the next spike to $7. If the news is extra poor, and wheat jumps back to the $11.40 per bushel it hit in March 2008, you could walk away with $32,000 -- per contract.

     In Hottest Investment Opportunities for 2010, you'll see also how play the most active commodities without leaving the stock market. You don't need to get involved with commodity brokers or futures contracts. You'll also find ways to increase your leverage and reduce your risk... all while sticking to widely held securities, with enough volume to get in and out quickly and safely.
 

Best Bond Play of 2010: Short Treasuries

     PIMCO's "bond king" Bill Gross calls U.S. Treasuries the "last, great financial bubble" and "the most overvalued asset in the world, bar none."

     We're not going to argue with the man who manages more bond money than anyone else in the world. And we can certainly see his logic...

     Under Obama's breathtaking spending, the federal budget deficit will jump to an all-time high of $1.5 trillion this fiscal year. Over the coming decade, it will swell by another $9 trillion.

     As the global economy recovers interest rates and inflation will rise sharply. Under no scenario are today's historically low interest rates on U.S. Treasuries sustainable.

     Just step back and look at history. The 10-year Treasury note yield has been in a long-term decline since the early '80s when it reached 15.8% at the height of inflation. It is now at 3.4%. But the gargantuan government bond issuance to fund the U.S. debt bubble will push yields steeply higher in coming year -- and bond prices steeply lower.

     We understand why the Fed is trying to clean up the mortgage-backed securities mess. But in trying to save the financial system by snapping up these toxic securities the Fed has simply created another dangerous credit bubble. You can't cure a problem caused by too much debt by issuing more debt.

     Bottom line: Bond investors are being presented with a once-in-a-lifetime opportunity to get their money out of U.S. Treasuries at a generational top. Sell what you have now... and position yourself for profits in the "reverse-bond" securities we profile in Hottest Investment Opportunities for 2010.
 

IT Play of the Year: The Release of Microsoft's Windows 7
Will Unleash a Tidal Wave of Business Spending

     There wasn't much hoopla surrounding the release of Microsoft's latest operating system. The company deliberately kept the buzz to a minimum. But we are convinced that the release of Windows 7 will prove to be a much bigger catalyst than Windows Vista, and will spur sales up and down the IT chain, from chips to PC makers to retailers.

     The previous version of Windows (Vista) was a sore disappointment. Big corporations shied away from the new software, and most opted to stand pat rather than make costly upgrades.

     Vista's failures have set the stage for an ever bigger replacement cycle this time around. Companies of all shapes and sizes that didn't make the leap to Vista are still relying on aging Windows XP systems. Hundreds of millions of outdated PCs worldwide need upgrades. We predict Windows 7 will be just the right fuse to spark an explosion in pent-up enterprise spending.

     Who will profit most? Not Microsoft. Vendors that supply components like semiconductors and hard drives will make the biggest gains.

     My staff and I like the near-term prospects for one particular PC maker that will be shipping 140,000 new computer systems per day... plus a retailer whose shelves are already loaded with Windows 7-related merchandise. You get the full write-up on these stocks in Hottest Investment Opportunities for 2010.
 

U.S. Treasury Sales Will Collapse, Ending the
Dollar's Reign as the World's Reserve Currency

Who owns America?      It might not be who you think. You have to go all the way back to the American Revolution (when foreign supporters like France bought our war bonds), to find so much U.S. debt held by foreigners.      In 1970, foreigners held just 3.8% of U.S. federal debt. They now own 27% (and 48% of U.S. Treasuries).

     China is the largest holder of U.S. debt. It holds more than $800 billion in U.S. treasuries -- 11% of the total. They see what is happening in Washington and they're nervous. China is calling loudly for the creation of a new reserve currency. So is Russia.

      Meanwhile, we're spending money we don't have. Our budget deficit is 13% of GDP. That's twice as big as our next-largest deficit since World War II.

Plus we're on the hook for $100 trillion in future payments for Social Security, Medicare and Medicaid, and government pensions.

     Guess what? Federal tax receipts come to $2.4 trillion a year. How are we going to pay $100 trillion without massive tax increases... defaulting on the government's promises... or both? None of which is exactly bullish for the future of the dollar as the world's safe-haven reserve currency.

     As exporters like China and India focus on domestic consumption to replace sliding sales to the U.S., demand for our debt will dry up... and the days of the U.S. dollar as the world's reserve currency will be numbered.

     To see how to profit from this mega-shift read on...
 

Best Currency Play of 2010

     Let's be clear: The U.S. dollar will continue to plummet in 2010.

     Currencies thrive on a positive balance of trade. But the U.S. is by far the world's largest debtor nation. Foreign central banks are ditching the dollar at a historic rate. Only 37% of their new foreign exchange holdings now go into greenbacks. (Historically, it's been the exact inverse, with 63% of new reserves going into dollars.)

     What are they using to replace the dollar? The euro and yen. The two currencies account for almost all of the new non-dollar reserves.

     Think about how poorly that speaks of the dollar. Even the euro -- the currency of a bitterly divided union of nations -- and the yen -- the currency of a country that's been in recession for a decade –are now both more attractive than the dollar.

     We think the dollar will remain under selling pressure for the next several years. Nothing out of Washington inspires confidence otherwise. Especially our all time-record budget deficit -- the highest of any nation in recorded history.

     Rather than bemoaning the fate of the dollar, we plan on making money from it. Sure, the euro and yen will continue to rally as the world pulls reserves away from the dollar. But our favorite currency play right now might surprise you: it's the Norwegian krone.

     This under-the-radar currency is a perfect safe haven. It just might be the best currency in the world.

     I have been bullish on Norway for several years now. The reason is simple: what is good for oil is good for Norway.

     Norway is a fiscal beacon: it actually has a budget surplus -- in contrast to the deepening deficits in the U.S., Europe and Japan. And its positive trade balance of 5% per cent of GDP is the biggest in the industrialized world. (Which explains why the cost for insurance against a default by the Norwegian government is the lowest of the world's ten most-traded currencies.)

     If you're worried about inflation, you need a commodity-based currency like the krone that rises in tandem with raw material prices. With our bullish outlook for oil we expect the krone to steadily appreciate for at least the coming year.

     In Hottest Investment Opportunities for 2010 we'll show you how to double, triple or even quadruple your money in only two months if the Norwegain krone rises five cents against our greenback. This is highly likely in the coming year, as skittish investors continue to flock to the safety of commodity-backed currencies. With the investment we recommend you know your risk in advance and you cannot lose more than you put up initially.
 

Most Surprising Economic Story of 2010 -- Marijuana

     California is in serious trouble. It has the lowest credit rating of any state and record 12.2% unemployment.

Its budget deficit is now $15 billion and is expected to reach $42 billion next year. While many states face budget shortfalls, only California's is more than one-third of its general fund. The state is so short on cash that it paid bills with IOUs from June through September. Its credit rating has been downgraded to just two notches above junk-bond status.

     But an unlikely white knight could gallop in to save California's economy: marijuana.

     A bill to legalize pot for adults is before the California legislature. The bill would regulate the cultivation of marijuana and impose a $50 per ounce fee on sales.

     By legalizing and taxing pot the state would reap huge new revenues: $2 billion a year. Pot is California's biggest cash crop, worth $14 billion a year. Vegetables are a distant second, taking in $5.7 billion. California's famous grapes generate just $2.6 billion.

     But instead of getting a cut of its #1 business, the state now spends money it doesn't have trying to shut down the industry and jailing its users.

    Next year Californians will vote to do a 180-degree about-face on the pot war, by legalizing marijuana statewide. Recent polls show that 60% of voters might approve the change. (In fact, Oakland already taxes cannabis sales, to the tune of $1 million a year.)

     How can investors profit from California's bold move? With a small pharma that has applied to the FDA for fast-track approval of its marijuana-based medicine to fight swine flu.

     The company is at the forefront of medical marijuana R&D. It is mission is to create cannabis-based medicines to fight disease and maintain general health. Its goal is to use cannabinoids to naturally reduce inflammatory immune responses, reduce mortality rates and allow infected individuals to develop a strong immunity upon recovery.

     You'll get details on this tiny startup in Hottest Investment Opportunities for 2010. If this stock is too speculative for your blood, we've found several other ways to profit as medical marijuana entrenches itself into mainstream pharmacology.

     There's a lot of money involved. Three legal drugs made with THC, the psychoactive ingredient in marijuana, are already on the market.

     Five of the world's biggest pharmaceutical companies are looking into pot's therapeutic possibilities... and there are 18 cannabinoid-related compounds under pharmaceutical development. Send for Hottest Investment Opportunities for 2010 and get the whole story on this surprising profit play that most investors have no clue about.
 

We'd also like to offer you the Surprise Energy Play of the Decade: Tiny Nuclear Power Plants Buried In Your Backyard

     There's no doubt among rational analysts that the safest, cheapest and cleanest form of energy is nuclear.

     But the future of nuclear energy doesn't lie in large, gigawatt-size plants. It lies in very small ones, the size of a backyard hot tub, that can be delivered on the back of a truck.

     These plants can be buried and run maintenance-free for up to 10 years, and produce enough electricity to power 20,000 homes. At about $25 million each, any town big enough for a Wal-Mart could have an almost infinite supply of cheap power.

     These small, portable and self-contained "nuclear batteries" are ideal for remote locations disconnected from the power grid. You can't have a Chernobyl because there are no moving parts. And it doesn't use enriched uranium. Nobody will steal it because it is literally too hot to handle. It would be like stealing a barbecue with your bare hands.

     The technology was developed by the government's nuclear labs at Los Alamos. It has been licensed to a company that already has orders and will be in production in 2013. Amazingly, this is not widely known. There has been little press coverage. So the most striking innovation in the energy field in decades will hit the general public out of left field.
 

How to Receive this Report Free

     All the predictions and investment opportunities I've mentioned here, and several others, are explored in detail in Hottest Investment Opportunities for 2010. We've put this report together because it's a perfect introduction to our Market Advisor newsletter.

     StreetAuthority Market Advisor is unlike any other financial advisory letter you've ever seen. What makes it so different?
 

Two Reasons Why StreetAuthority Market Advisor  Is Unique

     #1: We Aim for Spectacular Gains (by Being Defiantly Contrarian). Despite all the rocket scientists and supercomputers on Wall Street, the best way to get rich from investing is the same low-tech approach that applied a century ago: to take advantage of ''mob mentality.'' That means buying when the crowd is selling (when bargains are plentiful), and selling when the crowd is buying (when you can reap huge gains).

     If you buy the same investments as everyone else, you're going to have the same performance as other people -- which is always mediocre. This is why Market Advisor is defiantly contrarian.

     It's an approach that has served us well. For example, every year I send my Market Advisor subscribers a confidential report on my favorite investing ideas for the upcoming year.

     While unpopular and out of fashion with most investors, these picks have beaten the market in six out of seven years. By searching out unloved contrarian stocks with strong catalysts behind them, I've generated a compound return of 95.6% versus just 25.6% for the S&P 500.

     #2: We Never Buy a Stock Without a Firm Catalyst in Mind. The secret to making money in stocks isn't just finding a great company. Microsoft is a great company that hasn't gone anywhere in years. Ditto for GE , Pfizer and Intel. All these flagship stocks are trading lower than they were 10 years ago.

     The secret is finding great companies that are poised to benefit from a future catalyst.

     Just as chemical catalysts speed reactions between substances... stock catalysts create a dramatic impact on a company's fortunes... and trigger a sudden rush into its stock.

     Catalysts come in all shapes and sizes. But here are three of the biggest ones I am constantly on the lookout for:

     A surprise takeover announcement -- Like we saw with our own position in Wrigley. When Mars made a takeover offer our shares jumped +23% in a single day. (We made a total of +78% on that one in less than two years.)

     A killer new product -- Like the iPod, which rescued Apple from being a marginal computer company... added tens of billions of dollars to the firm's market cap... and catapulted its stock from $9 to nearly $200.

     Radically new business conditions -- Like the rush into Caterpillar stock when the bull market in commodities kicked off five years ago and triggered a seller's market for its products. This major new catalyst for Caterpillar pushed up its revenue by +100%, its profit by +220%, and its stock price by over +200%.
 

How We Find Stocks With Strong Catalysts

     To help me pinpoint stocks with the most powerful catalysts behind them, I've developed my own Catalyst Rating System. This tool helps me quantify the real strength behind a stock, rather than just going by a hunch that ''things look good'' for it.

     These catalyst-driven picks have outperformed the market by a long shot. In fact, my ''Beat the S&P'' Portfolio has returned six times as much as the S&P 500 .

     The average total return of every recommendation in the six years since we started this portfolio in May, 2003 is +91.3%. Meanwhile the S&P 500 is up +14.0%.

     Because it works so well, I've made my Catalyst Rating System the backbone of my newsletter. This rating system is behind all my investment decisions. And the only place you'll find it is in Market Advisor.

     In fact, StreetAuthority Market Advisor is the only service combining a strict contrarian discipline with catalyst investing. So if you want to know which securities have the strongest catalysts on the market today, there's no other place to look.
 

Two Ways to Receive Both StreetAuthority Market Advisor and Hottest Investment Opportunities for 2010

     So there you have it.  The approach I've described here, as exemplified by the extraordinary opportunities outlined in Hottest Investment Opportunities for 2010, guide every recommendation in my newsletter.  These techniques have served our readers exceedingly well, and I believe they will lead you to investment performance that surpasses anything you've ever experienced. 

     In fact, we're so confident about how well you can do with the help of StreetAuthority Market Advisor , we're prepared to offer you a special discounted annual rate of $99 or $179 for two years.

     And don't forget that since a subscription can be entirely tax-deductible if you use it for business or investment purposes, its true cost is much less. It all adds up to quite an opportunity -- and I urge you to take advantage of it today.